bcbs fep glp 1 coverage 2025 Bad News re: (Federal Employee Program, FEPBlue) Coverage of Obesity Therapies in
Description
15.0 kg (semaglutide) Waist circumference reduction: 18.4 cm (tirzepatide) vs
-cell Glp1r/ mice were generated by crossing MIP-CreERT with floxed-Glp1r mice as previously described [40]
Fudim M, White J, Pagidipati NJ, Lokhnygina Y, Wainstein J, Murin J, et al
Systolic blood pressure reduction with tirzepatide in patients with type 2 diabetes: Insights from SURPASS clinical program
Study findings The current study included 351,913 adult patients with an average age of 65.3 years, with nearly equal representation of male and female patients
I understand that I can revoke this consent at any time
